Global Glucose Dehydrogenase Market Strategic Research Report

Scope of the Report

The global Glucose Dehydrogenase market size is predicted to grow from US$ 350 million in 2025 to US$ 558 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.

Glucose dehydrogenase (GDH) is an oxidoreductase that catalyzes the oxidation of glucose to gluconolactone while reducing cofactors such as NAD⁺, PQQ, or FAD. It is widely used in blood glucose monitoring, biosensors, in vitro diagnostics (IVD), and biocatalysis. Depending on cofactors, GDH is classified into NAD-dependent, FAD-dependent, and PQQ-dependent types, with PQQ-GDH being widely used in continuous glucose monitoring (CGM) systems. In 2025, global sales volume of glucose dehydrogenase amounted to 341 tons, with an average selling price of $1,050 per Kg and an industry gross margin of 50%–75%. The glucose dehydrogenase industry chain consists of upstream raw materials and strain engineering, midstream enzyme manufacturing, and downstream applications. The upstream segment includes genetically engineered strains (e.g., E. coli, Bacillus subtilis), expression vectors, and fermentation media, with high technical barriers, especially for PQQ-GDH systems. The midstream involves enzyme production through fermentation, purification, lyophilization, and stabilization, representing the core value-added stage. Downstream applications include IVD (glucose test strips, CGM sensors), biosensors, food testing, and biocatalysis. With rising diabetes prevalence and CGM adoption, medical demand is rapidly increasing. The industry is also shifting toward higher stability, longer enzyme lifespan, and reduced interference, driving recombinant enzyme engineering as a key R&D direction.

Key market drivers for glucose dehydrogenase (GDH) include the growing global diabetic population, which continues to increase demand for glucose monitoring; rapid adoption of continuous glucose monitoring (CGM) systems, where GDH serves as a core biorecognition enzyme; rising penetration of point-of-care testing (POCT) devices in primary healthcare and homecare settings; advances in biotechnology that improve recombinant GDH production efficiency and reduce manufacturing costs; and expanding applications in food safety testing and industrial biocatalysis. In addition, high-stability technologies such as FAD-GDH are gradually replacing conventional glucose oxidase (GOx) systems in high-end diagnostics. Global aging trends and increasing chronic disease management demand are also strengthening the importance of GDH in healthcare diagnostics. On the risk side, GDH still faces competition from alternative enzyme technologies such as GOx, which retains cost advantages in some low-end applications. Technical barriers related to engineered strains, expression systems, and fermentation processes remain high, making market entry difficult for new players. Strict IVD and medical device regulations, especially in the US and European markets, may slow product approvals and commercialization. Fluctuations in fermentation media, purification materials, and bioprocessing costs can also affect profitability. In addition, the CGM market is highly concentrated, giving major downstream players strong bargaining power over upstream GDH suppliers. Diagnostic-grade GDH products also require extremely high stability, anti-interference capability, and batch consistency, increasing ongoing R&D and quality-control investment requirements.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glucose Dehydrogenase market?

What factors are driving Glucose Dehydrogenase market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glucose Dehydrogenase market opportunities vary by end market size?

How does Glucose Dehydrogenase break out by Type, by Application?

This report presents a comprehensive overview of the global Glucose Dehydrogenase market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• NAD-dependent GDH
• FAD-dependent GDH
• PQQ-dependent GDH

Segment by Source

• Microbial-derived
• Recombinant Enzyme
• Native Extraction

Segment by Form

• Lyophilized Powder
• Liquid Enzyme
• Immobilized Enzyme

Segment by Application

• Glucose Test Strips
• Continuous Glucose Monitoring
• IVD / POCT Testing
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Glucose Dehydrogenase market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Glucose Test Strips, Continuous Glucose Monitoring, IVD / POCT Testing evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact